Hilton Outpaces Peers as Analysts Race to Raise Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
HLT has gained 9% over the past week to $359.29, pulling ahead of its closest hospitality peers at a moment when the Street is revising upward in near-unison.
Among the peer group, MAR rose 6.9% on the week and H added 8.1%. CHH came closest to matching Hilton's pace, up 9.2%. Hilton's own 9% move put it at the top of the group by a narrow margin, continuing a pattern that has seen the stock climb 17.5% over the past month. The stock now trades at $359.29 against a Street mean target of $355, meaning the consensus, taken in aggregate, is already slightly behind the price. That gap matters because it reflects how quickly the targets have been moving rather than any skepticism about the name.
The analyst revision trend is the defining feature of this week's setup. JP Morgan raised its target to $387 on October 21, maintaining Overweight, while Wells Fargo lifted to $383 and Evercore ISI moved to $375, both within the past three days. Barclays had already raised to $384 on October 16. The direction of travel is consistent: every firm that moved this week went higher and none changed their positive ratings. Morgan Stanley's $336 target, raised earlier in the month, now sits furthest below the pack and furthest below the current price, a reflection of a more conservative base case rather than any bearish view. The factor score on analyst recommendation divergence ranks at the 92nd percentile, meaning the Street's positive skew on Hilton is wider than for nearly all comparable names. The EV/EBITDA multiple has expanded to 21.3x, up roughly half a turn over the past month as the stock has re-rated higher, and the PE has moved to 35.4x. Value ranks in the 16th percentile on ORTEX factor scores, confirming what the multiples show: this is not a cheap stock.
Borrow conditions remain entirely unconstraining for anyone on either side of the trade. Shares available to borrow are effectively uncapped, with availability far exceeding any practical demand from short sellers. The cost to borrow has oscillated through October, ending the week at 0.39%, but the range has been narrow and poses no friction. Short interest at 2.4% of float, with a modest 1.3% increase on the week, carries no real weight as a signal. The ORTEX short score of 33.2 is consistent with that: low and stable, with no directional move over the past two weeks. Options positioning has shifted further in the bullish direction since the earnings preview published on October 18. The put/call ratio has dropped to 0.68, now 1.6 standard deviations below its 20-day average of 0.75, and well below the midpoint of its 52-week range. Call positioning is running heavier relative to puts than it has for most of the past year.
Wikipedia attention toward Hilton is running at a z-score of 2.1 against its own 90-day history, indicating above-average retail interest at a time when the stock is near a 52-week high. The next earnings event is scheduled for October 27, and the prior Q2 print produced a 1-day move of minus 2.8% and a five-day move of minus 5.7%. That reaction sets the reference point for how the market has responded to results even in a broadly positive operating environment.
The level worth watching is the analyst mean target. At $355, it has already been overtaken by the price. As the remaining firms that have not yet revised update their models after the October 27 print, whether the consensus re-anchors above or below the current price will define whether the recent re-rating holds.
Stocks in this article
See the live data behind this article on ORTEX.
Open HLT on ORTEX →How this article was generated
- Generated
- 21 Oct 2026, 20:02
- Data as of
- 21 Oct 2026, 20:01
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.